Cargando…

Non-nuclear AR Signaling in Prostate Cancer

Despite the key role played by androgen receptor (AR) in tumor cell aggressiveness and prostate cancer (PCa) progression, its function in the tumor microenvironment (TME) is still controversial. Increasing studies highlight the crucial role played by TME modulation in treatment outcome and tumor cel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zamagni, Alice, Cortesi, Michela, Zanoni, Michele, Tesei, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775214/ https://www.ncbi.nlm.nih.gov/pubmed/31616657 http://dx.doi.org/10.3389/fchem.2019.00651

Ejemplares similares

The Role of Mesenchymal Stem Cells in Radiation-Induced Lung Fibrosis
por: Zanoni, Michele, et al.
Publicado: (2019)

Investigating the Benefit of Combined Androgen Modulation and Hypofractionation in Prostate Cancer
por: Zamagni, Alice, et al.
Publicado: (2020)

Modeling neoplastic disease with spheroids and organoids
por: Zanoni, Michele, et al.
Publicado: (2020)

Pan-Sigma Receptor Modulator RC-106 Induces Terminal Unfolded Protein Response In In Vitro Pancreatic Cancer Model
por: Cortesi, Michela, et al.
Publicado: (2020)

Sigma Receptors as Endoplasmic Reticulum Stress “Gatekeepers” and their Modulators as Emerging New Weapons in the Fight Against Cancer
por: Tesei, Anna, et al.
Publicado: (2018)

TP53 drives abscopal effect by secretion of senescence-associated molecular signals in non-small cell lung cancer
por: Tesei, Anna, et al.
Publicado: (2021)

Irradiation causes senescence, ATP release, and P2X7 receptor isoform switch in glioblastoma
por: Zanoni, Michele, et al.
Publicado: (2022)

The androgen receptor/filamin A complex as a target in prostate cancer microenvironment
por: Di Donato, Marzia, et al.
Publicado: (2021)

3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained
por: Zanoni, Michele, et al.
Publicado: (2016)

Correction to: The androgen receptor/filamin A complex as a target in prostate cancer microenvironment
por: Di Donato, Marzia, et al.
Publicado: (2021)

GABARAPL1 Promotes AR+ Prostate Cancer Growth by Increasing FL-AR/AR-V Transcription Activity and Nuclear Translocation
por: Su, Bing, et al.
Publicado: (2019)

AR-Signaling in Human Malignancies: Prostate Cancer and Beyond
por: Schweizer, Michael T., et al.
Publicado: (2017)

AR Signaling in Human Malignancies: Prostate Cancer and Beyond
por: Antonarakis, Emmanuel S.
Publicado: (2018)

Lysine Acetyltransferases and Their Role in AR Signaling and Prostate Cancer
por: Jaiswal, Bharti, et al.
Publicado: (2022)

Exploring the RC-106 Chemical Space: Design and Synthesis of Novel (E)-1-(3-Arylbut-2-en-1-yl)-4-(Substituted) Piperazine Derivatives as Potential Anticancer Agents
por: Listro, Roberta, et al.
Publicado: (2020)

AR Signaling and the PI3K Pathway in Prostate Cancer
por: Crumbaker, Megan, et al.
Publicado: (2017)

ACK1–AR and AR–HOXB13 signaling axes: epigenetic regulation of lethal prostate cancers
por: Kim, Eric H, et al.
Publicado: (2020)

Selective inhibitors of nuclear export: potential therapeutics for AR variant-expressing prostate cancer
por: Antonarakis, Emmanuel S.
Publicado: (2018)

Preclinical evidence of multiple mechanisms underlying trastuzumab resistance in gastric cancer
por: Arienti, Chiara, et al.
Publicado: (2016)

Therapeutic targeting of the androgen receptor (AR) and AR variants in prostate cancer
por: Narayanan, Ramesh
Publicado: (2020)

AR-V7 exhibits non-canonical mechanisms of nuclear import and chromatin engagement in castrate-resistant prostate cancer
por: Kim, Seaho, et al.
Publicado: (2022)

Stromal TGF-β signaling induces AR activation in prostate cancer
por: Yang, Feng, et al.
Publicado: (2014)

AR, the cell cycle, and prostate cancer
por: Balk, Steven P., et al.
Publicado: (2008)

Undesirable Status of Prostate Cancer Cells after Intensive Inhibition of AR Signaling: Post-AR Era of CRPC Treatment
por: Makino, Tomoyuki, et al.
Publicado: (2021)

Increased AR expression in castration-resistant prostate cancer rapidly induces AR signaling reprogramming with the collaboration of EZH2
por: Labaf, Maryam, et al.
Publicado: (2022)

Novel non-AR therapeutic targets in castrate resistant prostate cancer
por: Toren, Paul J., et al.
Publicado: (2013)

Targeted non AR mediated smart delivery of abiraterone to the prostate cancer
por: Baker, Abu, et al.
Publicado: (2022)

Co-expression and clinical utility of AR-FL and AR splice variants AR-V3, AR-V7 and AR-V9 in prostate cancer
por: Wüstmann, Neele, et al.
Publicado: (2023)

CDKN1A upregulation and cisplatin-pemetrexed resistance in non-small cell lung cancer cells
por: Zamagni, Alice, et al.
Publicado: (2020)

PAQR6 Upregulation Is Associated with AR Signaling and Unfavorite Prognosis in Prostate Cancers
por: Yang, Min, et al.
Publicado: (2021)

Stilbene Induced Inhibition of Androgen Receptor Dimerization: Implications for AR and ARΔLBD-Signalling in Human Prostate Cancer Cells
por: Streicher, Wolfgang, et al.
Publicado: (2014)

The interplay between AR, EGF receptor and MMP-9 signaling pathways in invasive prostate cancer
por: Mandel, Anna, et al.
Publicado: (2018)

AR Signaling in Breast Cancer
por: Rahim, Bilal, et al.
Publicado: (2017)

PLCɛ maintains the functionality of AR signaling in prostate cancer via an autophagy-dependent mechanism
por: Quan, Zhen, et al.
Publicado: (2020)

Crosstalk Between AR and Wnt Signaling Promotes Castration-Resistant Prostate Cancer Growth
por: Luo, Jun, et al.
Publicado: (2020)

Molecular Phenotyping of AR Signaling for Predicting Targeted Therapy in Castration Resistant Prostate Cancer
por: Hamid, Agus Rizal A. H., et al.
Publicado: (2021)

A COP1-GATA2 axis suppresses AR signaling and prostate cancer
por: Shen, Tao, et al.
Publicado: (2022)

Somatic Alterations Impact AR Transcriptional Activity and Efficacy of AR-Targeting Therapies in Prostate Cancer
por: Chauhan, Gaurav, et al.
Publicado: (2021)

Density Distribution Maps: A Novel Tool for Subcellular Distribution Analysis and Quantitative Biomedical Imaging
por: De Santis, Ilaria, et al.
Publicado: (2021)

Preclinical Models in Prostate Cancer: Resistance to AR Targeting Therapies in Prostate Cancer
por: Devlies, Wout, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c04c9i9hsb138ngoskstpnl0mg